USDJPY: Resistance will again be seen at 111.50/60
|US$Jpy chopped around either side of 111.00 on Friday but managed to close towards the higher end of the range despite the failure of Congress to pass the US Healthcare bill.
In the short term, the short term charts are still pointing a little higher suggesting that the downside will once again remain supported at 110.50/60 on Monday, but as before, with the dailies pointing lower, selling rallies does appear to be the dominant theme. If we do take out 110.60, and the option related bids ahead of 110.50, there is then little support to be seen until 110.10, which should be strong, below which would find buyers at 109.85/90. Under there, it again becomes pretty thin until around 109.35 and 109.00. On the topside, resistance will again be seen at 111.50/60, ahead of the initial Fibo resistance at 111.75, a break of which could see a run back to 112.00/25 although this seems doubtful today. Selling rallies, with a SL placed above 112.10 seems to be the plan on Monday.
Economic data highlights will include:
M:
T:
W: Retail Sales/Trade (Feb)
T: Foreign Bond/Stocks Investment
F: CPI, Unemployment, Industrial Production, Housing Starts, Construction Orders
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.